Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110002986A enables green water-phase oxidation. Eliminates organic solvents for cost reduction. Reliable supply chain for high-purity fluorenone intermediates.
Patent CN102659705A reveals a novel base-mediated route for 3,4-disubstituted isoxazoles, offering high yields and simplified supply chains for drug manufacturing.
Patent CN104024201B details a selective vanadium-catalyzed oxidation of nerolidol to farnesal, offering cost reduction in pharma intermediate manufacturing and enhanced supply reliability.
Patent CN111548325A details a novel synthesis of 7-chloro-benzothiazepine-1,1-dioxide, offering improved yield and halogen introduction for reliable pharmaceutical intermediate supply chains.
Patent CN101659668A discloses novel routes for Irinotecan and Topotecan intermediates, offering significant cost reduction in API manufacturing through improved oxidation and alkylation strategies.
Patent CN106518663B reveals metal-free synthesis for alpha-acyloxy ketones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced Mn(III)-Salen catalyst patent CN104030975A enables cost reduction in fine chemical manufacturing with stable supply chain and high selectivity.
Patent CN110922350B reveals a green, metal-free route for C2-acyloxylation of oxindoles using KI/H2O2, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108084129B details a novel enantioselective Baeyer-Villiger oxidation for prostaglandin intermediates, offering high ee values and scalable manufacturing solutions.
Patent CN104961692A reveals high-yield Demoxepam synthesis via tungstate catalysis. Reduced waste and enhanced purity offer significant advantages for global pharmaceutical supply chains and procurement strategies.
Patent CN116574039B details a novel cyanation method offering regioselectivity and reduced toxicity for pharmaceutical intermediates. This process enables significant cost reduction and supply chain reliability for global buyers.
Patent CN113121323B reveals a high-yield, two-step synthesis of p-hydroxybenzaldehyde using aluminum/zinc salts and copper ferrite, offering significant cost reduction and supply chain stability.
Patent CN109320434A reveals ionic iron catalysts for benzylamine synthesis offering green chemistry advantages and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113105402B details a novel iodine-promoted synthesis of 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharma manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402A reveals a novel iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.